Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has the Implantable Drug Delivery Devices Market Growth Performance Trended Historically, And What Lies Ahead?
In recent times, the market size for implantable drug delivery devices has witnessed robust expansion. The expansion is projected to advance from $20.65 billion in 2024 to $22.11 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. Several factors appear to hold the credit for the historical period growth, including an aging population, prevalence of chronic illnesses, rising consumer awareness, an increased emphasis on preventive healthcare, along with an increasing demand for personalized medicine.
What Is the Forecast for the Implantable Drug Delivery Devices Market Size Through 2029?
The market for implantable drug delivery devices is predicted to experience impressive growth in the upcoming years, escalating to $31.25 billion in 2029 with a compound annual growth rate (CAGR) of 9.0%. Factors contributing to this projected growth within the forecast period involve personalized drug delivery, the increasing preference for minimally invasive procedures, elevated healthcare spending, worldwide healthcare advancements, regenerative and genomic medicine. Key trends anticipated during the forecast period encompass ground-breaking technological developments, progress in biotechnology, micro-implants, dosage adjustments powered by artificial intelligence, integration with telemedicine, superior biocompatible materials, and innovative enhancements in drug delivery technology.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3303&type=smp
What are the Key Market Players in Implantable Drug Delivery Devices Market and How They’re Evolving?
Major companies operating in the implantable drug delivery devices market include AbbVie Inc., Bayer HealthCare, Medtronic Inc., Nucletron, Boston Scientific Corporation, Abbott Laboratories, Bausch and Lomb Inc., Merck & Co. Inc., Genentech Inc, EyePoint Pharmaceuticals Inc., DSM Biomedical, Delpor Inc., Teleflex Incorporated, 3M Company, Biotronik Inc., Alcon Inc., Terumo Corporation, Endologix Inc., TransEnterix Inc., China Grand Pharmaceutical and Healthcare Holdings, Innocoll Biotherapeutics, Atossa Therapeutics Inc., Intersect ENT, Microchips Biotech, Theradaptive Inc., CollPlant, Intarcia Therapeutics, Glaukos Corporation
What Are the Primary Growth Drivers in the Implantable Drug Delivery Devices Market?
The implantable drug delivery devices market is anticipated to get a significant boost from the escalating prevalence of target illnesses like cancer, diabetic retinopathy, cardiovascular diseases, and several other chronic conditions. For example, the Centers for Disease Control and Prevention, a governmental agency based in the US, reported that TB cases surged from 8,320 in 2022 to 9,615 in 2023, signifying a hike of 1,295 cases or 16%. The implantable drug devices’ ability to administer site-specific medication, thus aiding in the treatment of these target diseases, contributes to the market’s expansion.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=3303&type=smp
What Are the Leading Segments in the Global Implantable Drug Delivery Devices Industry?
The implantable drug delivery devices market covered in this report is segmented –
1) By Product: Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug-Eluting Stents, Bio-absorbable Stents, Intraocular Stents, Infusion Pumps, Other Applications
2) By Technology: Diffusion, Osmotic, Magnetic, Other Technologies
3) By Application: Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases, Other Applications
Subsegments:
1) By Contraceptive Implants: Hormonal Contraceptive Implants, Non-hormonal Contraceptive Implants
2) By Spinal Implants: Biodegradable Spinal Implants, Non-biodegradable Spinal Implants
3) By Brachytherapy Seeds: Iodine-125 Seeds, Palladium-103 Seeds, Cesium-131 Seeds, Other Brachytherapy Seeds
4) By Drug-Eluting Stents: Coronary Drug-Eluting Stents, Peripheral Drug-Eluting Stents
5) By Bio-absorbable Stents: Polymer-based Bio-absorbable Stents, Metal-based Bio-absorbable Stents
6) By Intraocular Stents: Glaucoma Intraocular Stents, Cataract Surgery Intraocular Stents
7) By Infusion Pumps: Insulin Pumps, Chemotherapy Infusion Pumps, Pain Management Infusion Pumps, Other Infusion Pumps
8) By Other Applications: Implantable Reservoirs, Implantable Micro-pumps, Implantable Drug Elution Devices
What Are the Key Market Trends in the Implantable Drug Delivery Devices Industry?
Corporations and scientific investigators are concentrating on creating 3D printing material to assist implantable drug delivery apparatus. The term refers to the specific materials used in 3D printing, or additive manufacturing procedures, to construct finely-tuned drug delivery systems. For example, a research published in the National Center for Biotechnology Information (NCBI) in 2022 suggested utilizing 3D-printed implants coupled with biodegradable rate-controlling membranes to generate devices that can deliver hydrophobic drugs over a prolonged period.
Access The Full Report Here:
What Is the Regional Outlook for the Implantable Drug Delivery Devices Market?
North America was the largest region in the implantable drug delivery devices market in 2023. Asia-Pacific was the second-largest region in the implantable drug delivery devices market report. The regions covered in the implantable drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3303
This Report Delivers Insight On:
1. How big is the implantable drug delivery devices market, and how is it changing globally?
2. Who are the major companies in the implantable drug delivery devices market, and how are they performing?
3. What are the key opportunities and risks in the implantable drug delivery devices market right now?
4. Which products or customer segments are growing the most in the implantable drug delivery devices market?
5. What factors are helping or slowing down the growth of the implantable drug delivery devices market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
